Modified double-stranded rna agents
US-2026098263-A1 · Apr 9, 2026 · US
Alnylam Pharmaceuticals Inc holds 889 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 889 |
| Recent patents | 267 |
| First publication | Jan 1, 2015 |
| Latest publication | Apr 9, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026098263-A1 · Apr 9, 2026 · US
US-12590305-B2 · Mar 31, 2026 · US
US-12584130-B2 · Mar 24, 2026 · US
US-12577564-B2 · Mar 17, 2026 · US
US-12569511-B2 · Mar 10, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026098263-A1 · Apr 9, 2026 · US
US-12590305-B2 · Mar 31, 2026 · US
US-12584130-B2 · Mar 24, 2026 · US
US-12577564-B2 · Mar 17, 2026 · US
US-12569511-B2 · Mar 10, 2026 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C12N2310/14 | 771 |
| C12N15/113 | 616 |
| C12N2310/315 | 616 |
| C12N2310/321 | 601 |
| A61K31/713 | 567 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 889 |
| Human Necessities | 786 |
| Cross-Sectional Technologies | 76 |
| Physics | 39 |
| Electricity | 5 |
| Operations & Transport | 3 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.